Intuitive Surgical (NSDQ:ISRG) said today that it won 510(k) clearance from the FDA for a new indication for its da Vinci SP robot-assisted surgery device and revealed plans to pursue other indications for the single-port device.

Initially cleared in April 2014 for urological procedures, the da Vinci SP’s newest indication is for procedures requiring very narrow access from a single small incision. Sunnyvale, Calif.-based Intuitive said it plans to ask the FDA to clear transoral, transanal, and extraperitoneal applications for the SP device.

“The da Vinci SP is the latest in our integrated product family that shows our commitment to improving minimally invasive surgery with technology that can positively impact patient outcomes,” CEO Gary Guthart said in prepared remarks. “Our da Vinci SP compliments da Vinci X and Xi systems by enabling surgeons to access narrow workspaces while maintaining high-quality vision, precision, and control that surgeons have come to trust from da Vinci systems.”

“Intuitive continues to bring tomorrow’s surgery today by addressing surgeon and patient needs, as well as working closely with hospitals to systematically improve the overall experience in the operating room,” added COO Salvatore Brogna.

Theranos whistleblower Tyler Shultz to participate in keynote interview at DeviceTalks Boston At DeviceTalks Boston, Tyler Shultz will give attendees an inside look at Theranos and how he was able to sound the alarm after he realized the company was falling apart. Shultz will take attendees behind the story that everyone is talking about: the rise and fall of Elizabeth Holmes and her diagnostic company, Theranos. Join Shultz and 1,000+ medical device professionals at the 8th annual DeviceTalks Boston. REGISTER NOW